hrs4r
Quiero donar
Firma
LLUÍS RAMIÓ-TORRENTÀ
Posición
Cap de Grup - R4
Jefe de Grupo - R4

Projectes

Codi oficial: RD21/0002/0063 - EM Data inicio:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: HZ16YWZ3K Data inicio:01/01/2022 Data fi: 30/06/2025 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA (AGAUR)

Publicacions

Gich J, Salavedra-Pont J, Coll-Martinez C, Quintana E, Álvarez-Bravo G, Robles-Cedeño R, Buxó M, Contreras-Rodriguez O, Ramió-Torrentà L

The nature of memory impairment in multiple sclerosis: understanding different patterns over the course of the disease

Frontiers in Psychology, 2024, 14, 1269794-1269794 dx.doi.org/10.3389/fpsyg.2023.1269794
Rosell-Díaz M, Santos-González E, Motger-Albertí A, Gallardo-Nuell L, Arnoriaga-Rodríguez M, Coll-Martínez C, Ramió-Torrentà L, Garre-Olmo J, Puig J, Ramos R, Mayneris-Perxachs J, Manuel Fernández-Real J

Lower serum ferritin levels are associated with worse cognitive performance in aging

JOURNAL OF NUTRITION HEALTH & AGING, 2024, 28, 100190-100190 dx.doi.org/10.1016/j.jnha.2024.100190
Alemany-Perna, B, Tamarit, J, Cabiscol, E, Delaspre, F, Miguela, A, Huertas-Pons, JM, Quiroga-Varela, A, Ruiz, MM, Dominguez, DL, Torrenta, L, Genis, D, Ros, J

Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients

MOVEMENT DISORDERS, 2024, 39, 1099-1108 dx.doi.org/10.1002/mds.29808
Fernández, OF, Costa-Frossard, L, Ginés, MLM, Escribano, PM, González, JMP, Ramió-Torrentà, L, Aladro, Y, Torres, AA, Rodríguez, EA, Labiano-Fontcuberta, A, Pascual, LL, Martínez, AM, Torres, EM, Oliva-Nacarino, P

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis

Frontiers in Neurology, 2024, 15 dx.doi.org/10.3389/fneur.2024.1371644
Rosell-Díaz M, Petit-Gay A, Molas-Prat C, Gallardo-Nuell L, Ramió-Torrentà L, Garre-Olmo J, Pérez-Brocal V, Moya A, Jové M, Pamplona R, Puig J, Ramos R, Bäckhed F, Mayneris-Perxachs J, Fernández-Real JM

Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 157, 155941-155941 dx.doi.org/10.1016/j.metabol.2024.155941
Tortosa-Carreres J, Cubas-Núñez L, Quiroga-Varela A, Castillo-Villalba J, Ramió-Torrenta L, Piqueras M, Gasqué-Rubio R, Quintanilla-Bordas C, Sanz MT, Lucas C, Huertas-Pons JM, Miguela A, Casanova B, Laiz-Marro B, Pérez-Miralles FC

Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 88, 105734-105734 dx.doi.org/10.1016/j.msard.2024.105734
Dominguez-Mozo MI, Galán V, Ramió-Torrentà L, Quiroga A, Quintana E, Villar LM, Costa-Frossard L, Fernández-Velasco JI, Villarrubia N, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R

A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.

Frontiers in Immunology, 2024, 15, 1384411-1384411 dx.doi.org/10.3389/fimmu.2024.1384411
Contreras-Rodriguez O, Blasco G, Biarnés C, Puig J, Arnoriaga-Rodríguez M, Coll-Martinez C, Gich J, Ramió-Torrentà L, Motger-Albertí A, Pérez-Brocal V, Moya A, Radua J, Manuel Fernández-Real J

Unraveling the gut-brain connection: The association of microbiota-linked structural brain biomarkers with behavior and mental health

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2024, 339-346 dx.doi.org/10.1111/pcn.13655
Fernández O, Montalbán X, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, García-Domínguez JM, Hernández MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Moral E, Prieto JM, Ramió-Torrentà L, Téllez N, Romero-Pinel L, Vilaseca A, Rodríguez-Antigüedad A

XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (I).

REVISTA DE NEUROLOGIA, 2024, 79, 21-29 dx.doi.org/10.33588/rn.7901.2024170
Meca-Lallana, JE, Yélamos, SM, Eichau, S, Llaneza, MA, Martínez, JM, Martínez, JP, Lallana, VM, Torres, AMA, Torres, EM, Rio, J, Calles, C, Luque, AA, Ramió-Torrentà, L, Sola, MEM, Prieto, JM, Ginés, MLM, Arroyo, R, Martínez, MAO, Ruiz, LB, Gutiérrez, MG, Zarranz, ARA, Sánchez-Seco, VG, Costa-Frossard, L, Pérez, MAH, Pascual, LL, Platas, MG, Oreja-Guevara, C

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

Neurologia, 2024, 39, 196-208 dx.doi.org/10.1016/j.nrl.2023.06.001

Formulari de contacte

Conoce el IDIBGI!

menu